Position in AVIR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$439,457
-$152,072 QoQ
Shares Held
94,507
-14.0% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 125 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. AVIR ranks #304 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $439,457 | 94,507 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $591,529 | 109,950 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $687,366 | 192,540 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $296,411 | 102,211 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $393,926 | 109,424 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $190,067 | 63,568 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $244,258 | 72,913 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $262,609 | 78,391 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $236,926 | 71,579 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $420,442 | 104,070 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $328,319 | 107,646 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $171,123 | 57,041 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $369,750 | 98,864 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $176,923 | 52,813 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $361,878 | 75,235 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $87,721 | 15,417 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $79,881 | 11,251 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $209,415 | 29,005 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $936,204 | 104,721 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,232,865 | 63,687 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,501,341 | 675,109 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $223,905 | 3,626 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $441,613 | 10,570 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||